VitroScan Receives €200K Grant from Medical:Forge Leipzig

Big news from the Leiden Bio Science Park community: VitroScan has been awarded a ~€200K grant as part of the Medical:Forge Leipzig accelerator. With support from leap:up and a growing network in Saxony, including WIG2 Institut and top oncology centers, VitroScan is laying the groundwork for market access in Germany. The team is already building…


Big news from the Leiden Bio Science Park community: VitroScan has been awarded a ~€200K grant as part of the Medical:Forge Leipzig accelerator. With support from leap:up and a growing network in Saxony, including WIG2 Institut and top oncology centers, VitroScan is laying the groundwork for market access in Germany.

The team is already building ties with local innovators like Healyan and MedicubeX, and exploring Leipzig’s vibrant healthtech scene.

Read more here.


  • VitroScan Achieves ISO‑15189 Compliance

    A Crucial Step Toward Introducing Predictive Testing Services into Clinical Practice Leiden, The Netherlands, 10 March 2026 — VitroScan is a Dutch biotech company developing predictive ex vivo micro‑tumor testing to help physicians make informed cancer treatment decisions. Today VitroScan announced that…

  • University Sportcentrum has Opened

    The University Sports Centre (USC) has been renovated, and we would love to take you on a quick tour of the building. Whether you are a colleague at LBSP, a student, or an external sports enthusiast: everyone is welcome to…